Farms.com Home   News

India to Open Market for U.S. Pork

The National Pork Producers Council (NPPC) today applauded the U.S. and Indian government’s announcement to allow imports of U.S. pork and pork products into India, the world’s second-most populous nation.

“After decades of work, a market that had been closed to U.S. pork is being opened,” said NPPC President Jen Sorenson. “NPPC thanks the Biden administration for reaching an agreement with India on market access for our products. We look forward to the new access, which will allow us to provide affordable, wholesome and nutritious U.S. pork products to consumers in India.”

India, which had a de facto ban on U.S. pork, has a population of 1.26 billion, meaning the potential market opportunity is significant. The agreement with the United States sets the stage for larger trade discussions.

In June 2019, the Office of the U.S. Trade Representative terminated India’s participation in the Generalized System of Preferences (GSP) program, which provides developing countries beneficial access to the U.S. market. USTR took that action because India did not provide equitable and reasonable U.S. access to its markets, including for U.S. pork.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.